0001104659-23-033307.txt : 20230316
0001104659-23-033307.hdr.sgml : 20230316
20230316160711
ACCESSION NUMBER: 0001104659-23-033307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20230316
DATE AS OF CHANGE: 20230316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berrey M Michelle
CENTRAL INDEX KEY: 0001397329
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 23738805
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08450
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 305 MADISON AVENUE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 305 MADISON AVENUE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tm239700-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-03-14
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001397329
Berrey M Michelle
C/O INTERCEPT PHARMACEUTICALS, INC.
305 MADISON AVENUE
MORRISTOWN
NJ
07960
0
1
0
0
President, R&D & CMO
Common Stock
2023-03-14
4
F
0
1246
15.79
D
82631
D
Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
/s/ Rocco Venezia
2023-03-16